Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The safety profile of cagrilintide, as observed in clinical trials , is primarily characterized by gastrointestinal disturbances , most notably mild to moderate nausea during the initial titration phase
Its amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with molecular formula CHNO and molecular weight of approximately 1,419.5 g/mol
However, once opened, the vial should be used within 28 days to maintain safety and efficacy, after which it should be discarded
However, headache incidence rates were similar between AOD-9604 and placebo groups, suggesting that many cases represented background occurrence rather than treatment-related effects
US$ 26.90
US$ 20.54
US$ 20.82
US$ 29.91
US$ 20.31
US$ 25.49
US$ 29.28
US$ 26.70
US$ 26.02
